Company Analysis

Pasithea Therapeutics Corp. (KTTA)

Nasdaq: KTTA · Pharmaceutical Preparations · Miami Beach, FL · filing with the SEC since 2021
Grade5.6
◀ Past 5.8● Present 4.6▶ Future 6.4
5 est.

Who runs Pasithea Therapeutics Corp.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Marques Tiago
Chief Executive Officer. First filing Sep 2021, latest May 5, 2026, 2 filings in all.
Officers reporting now
3
of 7 people with a filing in the last fifteen months
Directors reporting now
4
10 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Marques TiagoChief Executive OfficerSep 2021May 5, 2026none
Schneiderman Daniel HChief Financial OfficerAug 2022May 5, 2026none
Krishnan KartikChief Medical OfficerMay 2026May 5, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Dumesnil SimondirectorSep 2021May 5, 2026none
Leahy EmerdirectorSep 2021May 5, 2026none
Novak Alfred JdirectorSep 2022May 5, 2026none
Steinman LawrencedirectorSep 2021May 5, 2026none
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Coastlands Capital LP10% ownerApr 2026Jun 22, 2026none
Earlier names on the record20, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton KTTA · research, not advice